Binqing Q. Wei
Genentech · 61 works · 4,903 citations · h-index 34
Top works
- Lead discovery using molecular docking
- A Model Binding Site for Testing Scoring Functions in Molecular Docking
- Hydrogen storage of dense-aligned carbon nanotubes
- A streamlined platform for high-content functional proteomics of primary human specimens
- Soft Docking and Multiple Receptor Conformations in Virtual Screening
- An effective way to lower catalyst content in well-aligned carbon nanotube films
- A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals
- Testing a Flexible-receptor Docking Algorithm in a Model Binding Site
- Vertical aligned carbon nanotubes grown on Au film and reduction of threshold field in field emission
- Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer
- Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton’s Tyrosine Kinase Inhibitor in Early Clinical Development
- Discovery of 2-{3-[2-(1-Isopropyl-3-methyl-1H-1,2–4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl]-1H-pyrazol-1-yl}-2-methylpropanamide (GDC-0032): A β-Sparing Phosphoinositide 3-Kinase Inhibitor with High Unbound Exposure and Robust in Vivo Antitumor Activity
- Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition
- Structure-based Inhibitor Discovery against Adenylyl Cyclase Toxins from Pathogenic Bacteria That Cause Anthrax and Whooping Cough
- Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody–drug conjugates
- Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy
- Identification of substituted 2-thio-6-oxo-1,6-dihydropyrimidines as inhibitors of human lactate dehydrogenase
- Discovery of Novel PI3-Kinase δ Specific Inhibitors for the Treatment of Rheumatoid Arthritis: Taming CYP3A4 Time-Dependent Inhibition
- Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties
- High-Throughput Cysteine Scanning To Identify Stable Antibody Conjugation Sites for Maleimide- and Disulfide-Based Linkers